Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Hypersensitivity Reaction

  Free Subscription

Articles published in J Dermatol

Retrieve available abstracts of 194 articles:
HTML format

Single Articles

    July 2021
  1. SONG D, Ran X, Chen Y, Li Z, et al
    Recurrent c.459 C>A mutation of the PERP gene results in severe Olmsted syndrome with congenital hypotrichosis, atopic dermatitis, and growth retardation.
    J Dermatol. 2021 Jul 15. doi: 10.1111/1346-8138.16060.

  2. KAMEI K, Hirose T, Yoshii N, Tanaka A, et al
    Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: A retrospective analysis of a cross-sectional questionnaire survey.
    J Dermatol. 2021 Jul 6. doi: 10.1111/1346-8138.16054.
    PubMed     Abstract available

  3. HASHIMOTO H, Ito T, Ohno F, Morisawa H, et al
    Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor.
    J Dermatol. 2021;48:e339-e340.

    June 2021
  4. OSADA A, Arimitsu T, Nakazaki H, Kin T, et al
    Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
    J Dermatol. 2021 Jun 28. doi: 10.1111/1346-8138.16042.

  5. MATSUTANI M, Imai Y, Inoue Y, Nakatani-Kusakabe M, et al
    Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.
    J Dermatol. 2021 Jun 22. doi: 10.1111/1346-8138.16039.
    PubMed     Abstract available

  6. UCHIDA H, Kamata M, Nagata M, Fukaya S, et al
    Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
    J Dermatol. 2021 Jun 20. doi: 10.1111/1346-8138.16024.

  7. HANADA M, Nakagawa M, Hamabata A, Amano H, et al
    Lipid transfer protein syndrome due to wild grape juice and various vegetables: A life-threatening food allergen.
    J Dermatol. 2021 Jun 11. doi: 10.1111/1346-8138.16010.
    PubMed     Abstract available

    May 2021
  8. HASHIZUME H, Fujiyama T, Kageyama R, Kaneko Y, et al
    Increased CD30(+) cells in skin lesions of drug-induced hypersensitivity syndrome: Are type-2 innate lymphoid cells present?
    J Dermatol. 2021 May 25. doi: 10.1111/1346-8138.15967.

  9. BOSMA AL, Ouwerkerk W, Gunal M, Hyseni AM, et al
    Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
    J Dermatol. 2021 May 19. doi: 10.1111/1346-8138.15939.
    PubMed     Abstract available

  10. ARAKAWA N, Inoue T, Tanji T, Amano H, et al
    Development of arthralgia during treatment with dupilumab in a patient with atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15965.

  11. SHIN HT, Lee SH, Yoon HS, Heo JH, et al
    Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells derived from bone marrow in five adults with moderate to severe atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15928.
    PubMed     Abstract available

  12. KAWAI R, Suzuki S, Tanaka A, Yamazaki M, et al
    Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
    J Dermatol. 2021 May 8. doi: 10.1111/1346-8138.15918.

  13. LUGER T, Adaskevich U, Anfilova M, Dou X, et al
    Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.
    J Dermatol. 2021 May 7. doi: 10.1111/1346-8138.15921.
    PubMed     Abstract available

  14. HAYASHI E, Imanishi H, Tateishi C, Sowa-Osako J, et al
    Acute generalized exanthematous pustulosis associated with human parvovirus B19 infection in an adolescent.
    J Dermatol. 2021;48:e236-e237.

    April 2021
  15. UJIIE I, Iwata H, Yoshimoto N, Izumi K, et al
    Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment.
    J Dermatol. 2021;48:502-510.
    PubMed     Abstract available

  16. MURASE C, Takeichi T, Sugiura K, Akiyama M, et al
    Acute generalized exanthematous pustulosis triggered by acetaminophen in an IL36RN variant heterozygote.
    J Dermatol. 2021;48:e186-e187.

  17. ITAMI A, Miyagaki T, Miyano K, Takeuchi S, et al
    Intravascular large B-cell lymphoma mimicking erythema nodosum: A case report and review of published works.
    J Dermatol. 2021;48:e184-e185.

    March 2021
  18. KONDO M, Taniguchi T, Umaoka A, Iida S, et al
    Immunoglobulin G levels against Staphylococcus aureus maintained before and after treatment of severe atopic dermatitis.
    J Dermatol. 2021 Mar 28. doi: 10.1111/1346-8138.15871.

  19. FURUKAWA H, Omura R, Sugiura K, Kanazawa N, et al
    Granular C3 dermatosis-like immunological manifestation found in a case of acute generalized exanthematous pustulosis: Implication for the mechanism in C3 deposition to the epidermal basement membrane zone.
    J Dermatol. 2021 Mar 21. doi: 10.1111/1346-8138.15853.

  20. TAKEUCHI S, Inoue K, Kuretake K, Kiyomatsu-Oda M, et al
    Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
    J Dermatol. 2021 Mar 20. doi: 10.1111/1346-8138.15843.
    PubMed     Abstract available

  21. VERGARA-DE-LA-CAMPA L, Torrado I, Recuero-Pradillo M, Torrelo A, et al
    Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
    J Dermatol. 2021 Mar 8. doi: 10.1111/1346-8138.15734.
    PubMed     Abstract available

  22. WOO YR, Han Y, Lee JH, Lee YB, et al
    Real-world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire-based study.
    J Dermatol. 2021 Mar 5. doi: 10.1111/1346-8138.15817.
    PubMed     Abstract available

    February 2021
  23. NOMURA T, Nakajima S, Kashiwa A, Matsuyama K, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
    J Dermatol. 2021 Feb 25. doi: 10.1111/1346-8138.15820.

  24. TANAKA A, Morioke S, Ohya Y, Shimojo N, et al
    Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood.
    J Dermatol. 2021 Feb 23. doi: 10.1111/1346-8138.15790.

  25. JO UH, Lee JY, Lee H, Kim DY, et al
    Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
    J Dermatol. 2021 Feb 19. doi: 10.1111/1346-8138.15676.
    PubMed     Abstract available

  26. SAEKI H
    Preface to Journal of Dermatology special issue: Atopic dermatitis.
    J Dermatol. 2021;48:129.

  27. FUJII M, Kishibe M, Ishida-Yamamoto A
    Case of hypocomplementemic urticarial vasculitis with Sjogren's syndrome successfully treated with oral corticosteroid and colchicine.
    J Dermatol. 2021;48:e112-e113.

  28. NAGAOKA S, Hayashi S, Mori S, Kaneko Y, et al
    A case of macular rash misleading to drug eruption in secondary syphilis.
    J Dermatol. 2021;48:e104-e105.

  29. KADOWAKI S, Kimura T, Shiraki M, Mizutani Y, et al
    Case of Muckle-Wells syndrome with erythema dominantly infiltrated by lymphocytes.
    J Dermatol. 2021;48:e100-e101.

    January 2021
  30. TANAKA A, Isei M, Kikuzawa C, Hinogami H, et al
    Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
    J Dermatol. 2021 Jan 13. doi: 10.1111/1346-8138.15753.

  31. SUGIOKA K, Goto H, Sugita K, Habe K, et al
    Palisaded neutrophilic granulomatous dermatitis, interstitial granulomatous dermatitis and IgA vasculitis associated with incomplete Sjogren's syndrome.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15738.
    PubMed     Abstract available

  32. BOSMA AL, Ouwerkerk W, Middelkamp-Hup MA
    Children with atopic eczema experiencing increased disease severity in the pollen season more often have hay fever at a young age and a dark skin type.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15750.
    PubMed     Abstract available

  33. SCHIELEIN MC, Tizek L, Baeumer D, Hillmann E, et al
    People-centered care for psoriasis and urticaria: Are we overlooking Internet addiction while only considering patients and physician settings?
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15740.
    PubMed     Abstract available

  34. MATSUBARA D, Takahagi S, Saito R, Kamegashira A, et al
    Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria.
    J Dermatol. 2021;48:56-63.
    PubMed     Abstract available

  35. FUKAYAMA M, Domoto Y, Sato S, Asano Y, et al
    Case of aquagenic urticaria: Case report and the results of histopathological examination.
    J Dermatol. 2021;48:88-91.
    PubMed     Abstract available

  36. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Metal patch testing in patients with oral symptoms.
    J Dermatol. 2021;48:85-87.
    PubMed     Abstract available

    December 2020
  37. MIYANO K, Tsunemi Y
    Current treatments for atopic dermatitis in Japan.
    J Dermatol. 2020 Dec 30. doi: 10.1111/1346-8138.15730.
    PubMed     Abstract available

  38. TEYE K, Koga H, Nagai A, Ohata C, et al
    Filaggrin gene (FLG) promoter polymorphisms are associated with atopic dermatitis in the Japanese population.
    J Dermatol. 2020 Dec 27. doi: 10.1111/1346-8138.15736.

  39. CHIEOSILAPATHAM P, Prinyaroj N, Jamjanya S, Kiratikanon S, et al
    Degos-like lesions as a cutaneous manifestation of cytomegalovirus infection: A rare and serious complication in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Dec 11. doi: 10.1111/1346-8138.15717.
    PubMed     Abstract available

  40. MOTOHASHI I, Takano T, Ie K, Hashimoto Y, et al
    Development of maculopapular exanthem in a COVID-19 patient.
    J Dermatol. 2020;47:e426-e427.

    November 2020
  41. CHIANG PH, Ng CY, Kuo TT, Hui RC, et al
    Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15562.
    PubMed     Abstract available

  42. PUNYARATABANDHU P, Chirachanakul P
    Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15625.
    PubMed     Abstract available

  43. ICHIYAMA S, Ito M, Hoashi T, Kanda N, et al
    Severe atopic dermatitis effectively treated with dupilumab changed from interleukin-5 inhibitors for concomitant severe bronchial asthma.
    J Dermatol. 2020 Nov 8. doi: 10.1111/1346-8138.15691.

    October 2020
  44. WENG YC, Juan CK, Ho HJ, Chang YL, et al
    Atopic dermatitis does not increase the risk of inflammatory bowel disease: A nationwide cohort study.
    J Dermatol. 2020 Oct 30. doi: 10.1111/1346-8138.15661.
    PubMed     Abstract available

  45. NAKAHARA T, Kido-Nakahara M, Tsuji G, Furue M, et al
    Basics and recent advances in the pathophysiology of atopic dermatitis.
    J Dermatol. 2020 Oct 29. doi: 10.1111/1346-8138.15664.
    PubMed     Abstract available

  46. AJIMA S, Sano Y, Hashizume H
    Quinolone immediate hypersensitivity due to topical ophthalmic preparations: a case report and review of literature.
    J Dermatol. 2020 Oct 28. doi: 10.1111/1346-8138.15669.
    PubMed     Abstract available

  47. SHIIYA C, Ouchi T, Funakoshi T, Amagai M, et al
    Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases.
    J Dermatol. 2020 Oct 18. doi: 10.1111/1346-8138.15639.

  48. ISHIURA N, Yanaba K, Nashiro K, Kudo M, et al
    Inhibitory role of interleukin-10 in the cutaneous reverse Arthus reaction.
    J Dermatol. 2020 Oct 15. doi: 10.1111/1346-8138.15641.
    PubMed     Abstract available

  49. FURUHASHI T, Oda T, Torii K, Nishida E, et al
    Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis.
    J Dermatol. 2020 Oct 9. doi: 10.1111/1346-8138.15638.

  50. MUTO J, Yoshida S, Doi C, Habu M, et al
    Dupilumab treatment of atopic dermatitis leading to successful treatment of alopecia universalis: A Japanese case report.
    J Dermatol. 2020 Oct 7. doi: 10.1111/1346-8138.15631.

    September 2020
  51. BORILOVA LINHARTOVA P, Gachova D, Lipovy B
    Responsiveness to i.v. immunoglobulin therapy in patients with toxic epidermal necrolysis: A novel pharmaco-immunogenetic concept.
    J Dermatol. 2020 Sep 15. doi: 10.1111/1346-8138.15583.
    PubMed     Abstract available

  52. SUZUKI K, Futamura K, Sato N, Nakamura M, et al
    Two cases of fermented soybean (natto) allergy diagnosed using the skin prick test and enzyme linked immunosorbent assay for poly-gamma-glutamic acid.
    J Dermatol. 2020 Sep 6. doi: 10.1111/1346-8138.15601.

    August 2020
  53. YE S, Yan F, Wang H, Mo X, et al
    Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population.
    J Dermatol. 2020 Aug 29. doi: 10.1111/1346-8138.15530.
    PubMed     Abstract available

  54. TORRES-NAVARRO I, Briz-Redon A, Botella-Casas G, Sahuquillo-Torralba A, et al
    Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2020 Aug 27. doi: 10.1111/1346-8138.15490.
    PubMed     Abstract available

  55. KAWADA M, Nobeyama Y, Goto Y, Nakama K, et al
    Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    J Dermatol. 2020 Aug 20. doi: 10.1111/1346-8138.15572.

  56. KANATANI Y, Miyagawa F, Ogawa K, Arima A, et al
    Parallel changes in serum thymus and activation-regulated chemokine levels in response to flare-ups in drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Aug 12. doi: 10.1111/1346-8138.15548.

  57. KAJITA A, Sato E, Imafuku S
    Hypersensitivity due to unfractionated heparin treatment in a pregnant woman.
    J Dermatol. 2020 Aug 11. doi: 10.1111/1346-8138.15551.

    July 2020
  58. SHEN MH, Liu MT, Chung WH, Lu CW, et al
    Toxic epidermal necrolysis induced by human herpesvirus 7 treated with a tumor necrosis factor-alpha inhibitor.
    J Dermatol. 2020 Jul 19. doi: 10.1111/1346-8138.15493.
    PubMed     Abstract available

  59. FURUE K, Ulzii D, Tanaka Y, Ito T, et al
    Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15507.
    PubMed     Abstract available

  60. KATOH N
    Emerging treatments for atopic dermatitis.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15504.
    PubMed     Abstract available

  61. UMEMOTO N, Demitsu T, Otaki K, Matsumoto T, et al
    Dupilumab therapy in Sezary syndrome misdiagnosed as atopic dermatitis: A case report.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15501.

  62. KAWASAKI Y, Kamata M, Shimizu T, Nagata M, et al
    Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15511.
    PubMed     Abstract available

  63. ENDO Y, Oka A, Uehara A, Toki S, et al
    Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug.
    J Dermatol. 2020 Jul 14. doi: 10.1111/1346-8138.15510.

  64. WATANABE T, Yamaguchi Y, Watanabe Y, Takamura N, et al
    Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 1. doi: 10.1111/1346-8138.15467.
    PubMed     Abstract available

    June 2020
  65. KATO M, Oiso N, Yanagihara S, Kawada A, et al
    Long-lasting allergic patch test reactions to dental metal allergens in a patient with palmoplantar pustulosis and pustulotic arthro-osteitis.
    J Dermatol. 2020 Jun 23. doi: 10.1111/1346-8138.15471.

  66. KATO A, Kamata M, Ito M, Uchida H, et al
    Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis.
    J Dermatol. 2020 Jun 17. doi: 10.1111/1346-8138.15464.
    PubMed     Abstract available

    May 2020
  67. KYUNG Y, Lee JS, Lee JH, Jo SH, et al
    Health-related behaviors and mental health states of South Korean adolescents with atopic dermatitis.
    J Dermatol. 2020 May 25. doi: 10.1111/1346-8138.15386.
    PubMed     Abstract available

  68. CHOI CW, Yang BR, Suh DI, Kim MS, et al
    Infection, antibiotic exposure and development of atopic dermatitis: A nationwide case-control study.
    J Dermatol. 2020 May 22. doi: 10.1111/1346-8138.15387.
    PubMed     Abstract available

  69. TOTSUKA M, Inomata N, Yamakawa K, Watanabe T, et al
    Plum anaphylaxis induced by sensitization to gibberellin-regulated protein: Possibility of cross-reactivity with Pru p 7 and Pru m 7.
    J Dermatol. 2020 May 18. doi: 10.1111/1346-8138.15395.

  70. SEKIGUCHI A, Ishikawa O, Motegi SI
    Case of zinc deficiency-induced dermatomyositis-like dermatitis: Association between absence of CD1a-positive Langerhans cells and development of dermatitis.
    J Dermatol. 2020 May 15. doi: 10.1111/1346-8138.15394.

  71. MUROTA H, Inoue S, Yoshida K, Ishimoto A, et al
    Cost of illness study for adult atopic dermatitis in Japan: A cross-sectional Web-based survey.
    J Dermatol. 2020 May 7. doi: 10.1111/1346-8138.15366.
    PubMed     Abstract available

    April 2020
  72. TOMII K, Deguchi T, Katsumi T, Suzuki T, et al
    Case of toxic epidermal necrolysis successfully treated with repeated i.v. immunoglobulin.
    J Dermatol. 2020 Apr 24. doi: 10.1111/1346-8138.15356.

  73. UETSU N, Nomura Y, Matsuyama Y, Okamoto H, et al
    Characteristics and clinical significance of augmentation spectra in solar urticaria.
    J Dermatol. 2020;47:369-377.
    PubMed     Abstract available

  74. SUO H, Su H, Lu C, Yang L, et al
    Development of generalized bullous lesions after hemodialysis with polysulfone membrane dialyzer.
    J Dermatol. 2020;47:e119-e120.

    March 2020
  75. NISHIMURA-TAGUI M, Hayama K, Fujita H, Sato N, et al
    Case of anaphylaxis due to lotus root.
    J Dermatol. 2020 Mar 30. doi: 10.1111/1346-8138.15329.

  76. TOHYAMA M, Hashimoto K, Oda F, Namba C, et al
    Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2020 Mar 11. doi: 10.1111/1346-8138.15294.
    PubMed     Abstract available

    February 2020
  77. MORIWAKI M, Umeda N, Ishii K, Morikawa H, et al
    Case of anaphylaxis to maltose solution.
    J Dermatol. 2020 Feb 13. doi: 10.1111/1346-8138.15263.

  78. KONDO M, Suzuki K, Nakayama Y, Matsushima Y, et al
    Case of toxic epidermal necrolysis in immunocompromised patient possibly due to Streptococcus pneumoniae serotype uncovered by vaccine.
    J Dermatol. 2020 Feb 13. doi: 10.1111/1346-8138.15268.

  79. MATSUDA-HIROSE H, Sho Y, Yamate T, Nakamura Y, et al
    Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    J Dermatol. 2020;47:e53-e54.

  80. IHIBASHI-KUNIMI Y, Imafuku S
    Cholinergic urticaria with hypohidrosis successfully treated with omalizumab.
    J Dermatol. 2020;47:e47-e48.

    January 2020
  81. CHEN CY, Chiang CP, Chen HC, Gao HW, et al
    Coexisting mutations in CARD14 and NUTD15 detected in a young female with azathioprine hypersensitivity syndrome manifested as acute generalized exanthematous pustulosis.
    J Dermatol. 2020 Jan 28. doi: 10.1111/1346-8138.15240.

  82. KIKUCHI S, Nobeyama Y, Saeki H, Asahina A, et al
    Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    J Dermatol. 2020 Jan 7. doi: 10.1111/1346-8138.15208.
    PubMed     Abstract available

  83. NAKAMURA K, Iwata Y, Asai J, Kawakami T, et al
    Guidelines for the treatment of skin and mucosal lesions in Behcet's disease: A secondary publication.
    J Dermatol. 2020 Jan 6. doi: 10.1111/1346-8138.15207.
    PubMed     Abstract available

  84. SATAKE M, Kudo K, Masuda A, Onoyama S, et al
    Drug-induced hypersensitivity syndrome by i.v. immunoglobulin administration for Kawasaki disease.
    J Dermatol. 2020 Jan 5. doi: 10.1111/1346-8138.15211.

  85. SAWADA H, Kanehisa F, Katoh N, Asai J, et al
    Potassium iodide in successful treatment of erythema nodosum-like lesions induced by combination therapy with dabrafenib and trametinib.
    J Dermatol. 2020;47:e7-e8.

    December 2019
  86. TAKAHASHI A, Namikawa K, Nakano E, Yamazaki N, et al
    Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma.
    J Dermatol. 2019 Dec 26. doi: 10.1111/1346-8138.15204.
    PubMed     Abstract available

  87. NAKAJIMA K, Lee MG, Bin BH, Hara T, et al
    Possible involvement of zinc transporter ZIP10 in atopic dermatitis.
    J Dermatol. 2019 Dec 25. doi: 10.1111/1346-8138.15190.

  88. HIGASHI Y, Baba N, Yoshimine H, Sakaguchi I, et al
    Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2019 Dec 16. doi: 10.1111/1346-8138.15175.
    PubMed     Abstract available

  89. GOTO H, Moriki M, Sano Y, Yagi H, et al
    Successful preoperative intervention of dupilumab in high-risk surgery in a patient with severe atopic dermatitis.
    J Dermatol. 2019 Dec 10. doi: 10.1111/1346-8138.15187.

  90. TAMAGAWA-MINEOKA R, Masuda K, Katoh N
    Allergic contact dermatitis due to neem oil: A case report and mini-review.
    J Dermatol. 2019 Dec 10. doi: 10.1111/1346-8138.15182.

  91. NAKAGAWA H, Nemoto O, Igarashi A, Saeki H, et al
    Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.
    J Dermatol. 2019 Dec 9. doi: 10.1111/1346-8138.15173.
    PubMed     Abstract available

    November 2019
  92. HASHIZUME H, Abe R, Azukizawa H, Fujiyama T, et al
    Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology.
    J Dermatol. 2019 Nov 28. doi: 10.1111/1346-8138.15164.
    PubMed     Abstract available

  93. YAMAZAKI E, Kikuchi K, Sasahara Y, Kono M, et al
    Atopic dermatitis without serum immunoglobulin E elevation or loss-of-function filaggrin gene mutation in a patient with X-linked agammaglobulinemia.
    J Dermatol. 2019 Nov 27. doi: 10.1111/1346-8138.15154.
    PubMed     Abstract available

  94. SAEKI H, Baba N, Oshiden K, Abe Y, et al
    Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopic
    J Dermatol. 2019 Nov 11. doi: 10.1111/1346-8138.15137.
    PubMed     Abstract available

  95. MITSUI Y, Ogawa K, Miyagawa F, Azukizawa H, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms or non-drug-related erythroderma with a persistent human herpesvirus 6 infection.
    J Dermatol. 2019 Nov 6. doi: 10.1111/1346-8138.15145.

    October 2019
  96. ONO R, Yagi M, Shoji A, Fujita K, et al
    Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis.
    J Dermatol. 2019 Oct 27. doi: 10.1111/1346-8138.15123.
    PubMed     Abstract available

  97. YAMAKAWA K, Inomata N, Fukuro K, Sano S, et al
    Fermented soybean-induced late-onset anaphylaxis in a 7-year-old junior surfer.
    J Dermatol. 2019 Oct 15. doi: 10.1111/1346-8138.15112.

  98. KATOH N, Ohya Y, Ikeda M, Ebihara T, et al
    Clinical practice guidelines for the management of atopic dermatitis 2018.
    J Dermatol. 2019 Oct 9. doi: 10.1111/1346-8138.15090.
    PubMed     Abstract available

  99. NIWA Y, Hayama K, Tagui T, Ito-Watanabe M, et al
    Case of anaphylaxis due to carmellose sodium.
    J Dermatol. 2019 Oct 6. doi: 10.1111/1346-8138.15107.

  100. OKAMOTO M, Takahagi S, Kamegashira A, Yanase Y, et al
    Successful treatment of refractory dermal pain with etizolam and clonazepam in a patient with acquired idiopathic generalized anhidrosis.
    J Dermatol. 2019;46:e351-e353.

  101. KUNIMOTO K, Honda-Ozaki F, Saito MK, Furukawa F, et al
    Beneficial effect of methotrexate on a child case of Nakajo-Nishimura syndrome.
    J Dermatol. 2019;46:e365-e367.

    September 2019
  102. CHIANG B, Kamiya K, Sashikawa M, Maekawa T, et al
    Rare case of acquired perforating dermatosis induced by cetuximab.
    J Dermatol. 2019 Sep 20. doi: 10.1111/1346-8138.15098.

  103. KIM YE, Kim TM, Jo SJ
    Histologically-diagnosed psoriasiform dermatitis induced by nivolumab successfully controlled by etanercept: A case report.
    J Dermatol. 2019 Sep 17. doi: 10.1111/1346-8138.15091.

  104. MAEKAWA A, Arase N, Tamai K, Nomura T, et al
    Case of epidermolytic ichthyosis with impairment of pulmonary function and exacerbated skin manifestations in a late middle-aged adult.
    J Dermatol. 2019 Sep 9. doi: 10.1111/1346-8138.15077.

  105. NAKAGAWA M, Hanada M, Amano H
    Occupational contact dermatitis in a manicurist.
    J Dermatol. 2019 Sep 4. doi: 10.1111/1346-8138.15062.
    PubMed     Abstract available

  106. ABE K, Itoh M, Asahina A
    Rituximab-induced vasculitis: Does the immune complex of rituximab play a key role in developing paradoxical adverse events?
    J Dermatol. 2019;46:e311-e312.

    August 2019
  107. TSAI TF, Rajagopalan M, Chu CY, Encarnacion L, et al
    Burden of atopic dermatitis in Asia.
    J Dermatol. 2019 Aug 22. doi: 10.1111/1346-8138.15048.
    PubMed     Abstract available

  108. WANG F, Gao X, Chen X, Tang X, et al
    Successful treatment of interstitial lung disease related to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review.
    J Dermatol. 2019 Aug 22. doi: 10.1111/1346-8138.15058.
    PubMed     Abstract available

  109. SAITO R, Tanaka A, Hiragun T, Iwamoto K, et al
    Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis.
    J Dermatol. 2019 Aug 2. doi: 10.1111/1346-8138.15036.

  110. YANG J, Wang G, Fu M
    Drug reaction with eosinophilia and systemic symptoms presenting as leukoencephalopathy.
    J Dermatol. 2019;46:e305-e307.

    July 2019
  111. HATTORI Y, Matsuyama K, Shu E, Seishima M, et al
    Eosinophilic pneumonia and esophagitis in a patient with malignant melanoma treated with nivolumab.
    J Dermatol. 2019 Jul 29. doi: 10.1111/1346-8138.15030.

  112. HORII M, Kobayashi T, Maeda S, Takehara K, et al
    Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor.
    J Dermatol. 2019 Jul 25. doi: 10.1111/1346-8138.15027.

  113. FURUE K, Ito T, Tsuji G, Esaki H, et al
    Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?
    J Dermatol. 2019 Jul 11. doi: 10.1111/1346-8138.15011.

  114. KATO M, Oiso N, Uchida S, Yanagihara S, et al
    Biologic-induced urticaria due to polysorbate 20.
    J Dermatol. 2019;46:e230-e232.

    June 2019
  115. IGARASHI A, Fujita H, Arima K, Inoue T, et al
    Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis.
    J Dermatol. 2019 Jun 27. doi: 10.1111/1346-8138.14947.
    PubMed     Abstract available

  116. OOSTERHAVEN JAF, Voorberg AN, Romeijn GLE, de Bruin-Weller MS, et al
    Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
    J Dermatol. 2019 Jun 12. doi: 10.1111/1346-8138.14982.
    PubMed     Abstract available

  117. MIHARA R, Kabashima K, Furue M, Nakano M, et al
    Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study.
    J Dermatol. 2019 Jun 5. doi: 10.1111/1346-8138.14934.
    PubMed     Abstract available

  118. TOTSUKA M, Watanabe Y, Asai C, Takahashi S, et al
    Case of severe bullous erythema including intertrigo-like eruptions with angioedema induced by pegylated liposomal doxorubicin.
    J Dermatol. 2019;46:535-539.
    PubMed     Abstract available

  119. FUJII H, Endo Y, Dainichi T, Otsuka A, et al
    Predictive factors of response to pulse methylprednisolone therapy in patients with alopecia areata: A follow-up study of 105 Japanese patients.
    J Dermatol. 2019;46:522-525.
    PubMed     Abstract available

  120. SUZUKI H, Miyagaki T, Sato S
    YKL-40 augments the proliferation of HaCaT cells via the extracellular regulatory kinase pathway.
    J Dermatol. 2019;46:551-552.

  121. SENDA N, Miyagaki T, Oka T, Nonogaki A, et al
    Case of purpuric drug eruption probably induced by panitumumab.
    J Dermatol. 2019;46:e221-e222.

    May 2019
  122. LIANG J, Li C, Zhang Z, Ni C, et al
    Severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome caused by de novo mutation in the DSP gene misdiagnosed as generalized pustular psoriasis and treatment of acitretin with gabapentin.
    J Dermatol. 2019 May 20. doi: 10.1111/1346-8138.14925.
    PubMed     Abstract available

  123. ASAI C, Watanabe Y, Mukaijo J, Takamura N, et al
    Case of toxic epidermal necrolysis occurring after bone marrow transplantation accompanied by engraftment failure.
    J Dermatol. 2019 May 20. doi: 10.1111/1346-8138.14913.
    PubMed     Abstract available

  124. FURUMURA Y, Nishida M, Imanishi A, Maekawa N, et al
    Infectious endocarditis with multiple cerebral infarctions in a patient with severe atopic dermatitis.
    J Dermatol. 2019 May 15. doi: 10.1111/1346-8138.14924.

  125. SHI X, Xiang X, Wang Z, Ma L, et al
    Chinese case of Nakajo-Nishimura syndrome with a novel mutation of the PSMB8 gene.
    J Dermatol. 2019;46:e160-e161.

  126. FUJIMURA T, Lyu C, Tsukada A, Sato Y, et al
    Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab.
    J Dermatol. 2019;46:e177-e178.

  127. NOMURA Y, Uetsu N, Kishimoto I, Okamoto H, et al
    Polymorphous light eruption with complication of solar urticaria revealed by phototesting.
    J Dermatol. 2019;46:e148-e149.

  128. MAILLET F, Wolff D, Soria A, Adnet F, et al
    Factors associated with relapses among patients treated for acute urticaria.
    J Dermatol. 2019;46:383-388.
    PubMed     Abstract available

    April 2019
  129. ITO M, Morita T, Okazaki S, Koto M, et al
    Dietary habits in adult Japanese patients with atopic dermatitis.
    J Dermatol. 2019 Apr 15. doi: 10.1111/1346-8138.14881.
    PubMed     Abstract available

  130. KANDA N, Koto M, Hoashi T, Saeki H, et al
    Case of alopecia areata during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2019 Apr 3. doi: 10.1111/1346-8138.14880.

  131. CARDENAS-DE LA GARZA JA, Ancer-Arellano J, Cuellar-Barboza A, Saenz-Ibarra B, et al
    Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
    J Dermatol. 2019;46:e128-e129.

    March 2019
  132. OKITA T, Yamaguchi M, Asano N, Yasuno S, et al
    Two Japanese families with hypohidrotic ectodermal dysplasia: Phenotypic differences between affected individuals.
    J Dermatol. 2019;46:e99-e101.

    February 2019
  133. EZZEDINE K, Visseaux L, Cadiot G, Brixi H, et al
    Ustekinumab for skin reactions associated with anti-tumor necrosis factor-alpha agents in patients with inflammatory bowel diseases: A single-center retrospective study.
    J Dermatol. 2019 Feb 28. doi: 10.1111/1346-8138.14816.
    PubMed     Abstract available

  134. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    J Dermatol. 2019 Feb 13. doi: 10.1111/1346-8138.14787.
    PubMed     Abstract available

  135. SHIBATA A, Yoshikawa T, Makita S, Takama H, et al
    Urticarial vasculitis and subcutaneous nodules in the extremities seen in a patient with mucopolysaccharidosis II after hematopoietic stem cell therapy.
    J Dermatol. 2019;46:e63-e64.

    January 2019
  136. TASHIRO Y, Azukizawa H, Asada H, Niihara H, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    J Dermatol. 2019 Jan 21. doi: 10.1111/1346-8138.14776.
    PubMed     Abstract available

  137. FUKAYAMA M, Asano Y, Shinozaki-Ushiku A, Sato S, et al
    Estrogen dermatitis: Case report and examination of estrogen receptor-beta in the skin.
    J Dermatol. 2019 Jan 10. doi: 10.1111/1346-8138.14750.
    PubMed     Abstract available

  138. YONG SB, Su KW, Chen HH, Huang JY, et al
    Impact of chronic urticaria on systemic lupus erythematosus: A nationwide population-based study in Taiwan.
    J Dermatol. 2019;46:26-32.
    PubMed     Abstract available

  139. DEMITSU T, Kawase M, Nagashima K, Takazawa M, et al
    Mycoplasma pneumoniae-associated mucositis with severe blistering stomatitis and pneumonia successfully treated with azithromycin and infusion therapy.
    J Dermatol. 2019;46:e38-e39.

    December 2018
  140. KUDO K, Masuda A, Mizobe T, Kihara J, et al
    Bullous artificial dermatitis due to aerosol sprays masquerading as fixed drug eruption.
    J Dermatol. 2018 Dec 19. doi: 10.1111/1346-8138.14729.

  141. SEO E, Yoon J, Jung S, Lee J, et al
    Phenotypes of atopic dermatitis identified by cluster analysis in early childhood.
    J Dermatol. 2018 Dec 6. doi: 10.1111/1346-8138.14714.
    PubMed     Abstract available

  142. OKA K, Ohtaki N, Igawa K, Yokozeki H, et al
    Study on the correlation between age and changes in mosquito bite response.
    J Dermatol. 2018;45:1471-1474.
    PubMed     Abstract available

    November 2018
  143. KURITA M, Yoshihara Y, Ishiuji Y, Chihara M, et al
    Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4(+) T cells in patients with atopic dermatitis.
    J Dermatol. 2018 Nov 7. doi: 10.1111/1346-8138.14696.
    PubMed     Abstract available

    October 2018
  144. NAKAI K, Haba R, Kushida Y, Kubota Y, et al
    Macrophages express betaKlotho in skin lesions of psoriatic patients and the skin of imiquimod-treated mice.
    J Dermatol. 2018 Oct 10. doi: 10.1111/1346-8138.14671.

  145. SUZUKI H, Sugaya M, Nakajima R, Oka T, et al
    Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.
    J Dermatol. 2018 Oct 5. doi: 10.1111/1346-8138.14665.
    PubMed     Abstract available

  146. KAGAMI S, Katori T
    Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    J Dermatol. 2018;45:1199-1202.
    PubMed     Abstract available

    September 2018
  147. SYU FK, Pan HY, Chuang PC, Huang YS, et al
    Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    J Dermatol. 2018;45:1080-1087.
    PubMed     Abstract available

    August 2018
  148. MORIWAKI M, Iwamoto K, Ishii K, Takahagi S, et al
    Case of anaphylaxis to lansoprazole confirmed by histamine release test and oral provocation test.
    J Dermatol. 2018 Aug 27. doi: 10.1111/1346-8138.14628.

  149. HAYASHI E, Sowa-Osako J, Fukai K, Natsumi A, et al
    Case of anaphylaxis caused by black ginger in a dietary supplement.
    J Dermatol. 2018 Aug 27. doi: 10.1111/1346-8138.14592.

  150. ITAKURA A, Tani Y, Kaneko N, Hide M, et al
    Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.
    J Dermatol. 2018;45:963-970.
    PubMed     Abstract available

  151. TAKAHASHI T, Minami S, Teramura K, Tanaka T, et al
    Four cases of acute infectious urticaria showing significant elevation of plasma D-dimer level.
    J Dermatol. 2018;45:1013-1016.
    PubMed     Abstract available

  152. UMEMURA H, Yamasaki O, Iwatsuki K
    Leukocytoclastic vasculitis associated with immunoglobulin A lambda monoclonal gammopathy of undetermined significance: A case report and review of previously reported cases.
    J Dermatol. 2018;45:1009-1012.
    PubMed     Abstract available

  153. KISHI C, Motegi SI, Yasuda M, Ishikawa O, et al
    Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
    J Dermatol. 2018;45:1020-1022.

    July 2018
  154. JUNG HJ, Bae JY, Kim JE, Na CH, et al
    Survey of disease awareness, treatment behavior and treatment satisfaction in patients with atopic dermatitis in Korea: A multicenter study.
    J Dermatol. 2018 Jul 18. doi: 10.1111/1346-8138.14540.
    PubMed     Abstract available

  155. YONG SB, Chen HH, Huang JY, Wei JC, et al
    Patients with urticaria are at a higher risk of anaphylaxis: A nationwide population-based retrospective cohort study in Taiwan.
    J Dermatol. 2018 Jul 13. doi: 10.1111/1346-8138.14532.
    PubMed     Abstract available

  156. FURUE M, Iida K, Imaji M, Nakahara T, et al
    Microbiome analysis of forehead skin in patients with atopic dermatitis and healthy subjects: Implication of Staphylococcus and Corynebacterium.
    J Dermatol. 2018;45:876-877.

    June 2018
  157. OHTSUKI M, Morimoto H, Nakagawa H
    Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
    J Dermatol. 2018 Jun 21. doi: 10.1111/1346-8138.14501.
    PubMed     Abstract available

  158. WANG Q, Tian XB, Liu W, Zhang LX, et al
    Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2018 Jun 13. doi: 10.1111/1346-8138.14488.
    PubMed     Abstract available

    May 2018
  159. HIRUMA J, Harada K, Motoyama A, Okubo Y, et al
    Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients.
    J Dermatol. 2018 May 24. doi: 10.1111/1346-8138.14478.
    PubMed     Abstract available

  160. TAKAHASHI H, Sato K, Takagi A, Iizuka H, et al
    Brodalumab-induced palmar pustular eruption and joint swelling accompanied by muscle pains in two cases of psoriasis.
    J Dermatol. 2018 May 16. doi: 10.1111/1346-8138.14463.

  161. YASUNO S, Yamaguchi M, Tanaka A, Umehara K, et al
    Case of generalized pustular psoriasis that might have progressed from terbinafine-induced acute generalized exanthematous pustulosis.
    J Dermatol. 2018 May 15. doi: 10.1111/1346-8138.14476.

  162. SEE JA, Goh CL, Hayashi N, Suh DH, et al
    Optimizing the use of topical retinoids in Asian acne patients.
    J Dermatol. 2018;45:522-528.
    PubMed     Abstract available

  163. TACHIBANA K, Hamada T, Tsuchiya H, Shibata T, et al
    Ethosuximide-induced Stevens-Johnson syndrome: Beneficial effect of early intervention with high-dose corticosteroid therapy.
    J Dermatol. 2018;45:592-595.
    PubMed     Abstract available

    April 2018
  164. IINUMA S, Kanno K, Honma M, Kinouchi M, et al
    Drug-induced hypersensitivity syndrome followed by chronic inflammatory demyelinating polyneuropathy.
    J Dermatol. 2018 Apr 19. doi: 10.1111/1346-8138.14333.

  165. NAKAGAWA H, Nemoto O, Yamada H, Nagata T, et al
    Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis.
    J Dermatol. 2018 Apr 17. doi: 10.1111/1346-8138.14322.
    PubMed     Abstract available

  166. SATO M, Uhara H, Koga H, Okuyama R, et al
    Efficacy and toxicity of ipilimumab used after nivolumab in patients with melanoma.
    J Dermatol. 2018 Apr 14. doi: 10.1111/1346-8138.14325.

    March 2018
  167. IRIKI H, Ouchi T, Ito H, Sawada M, et al
    Case of lamotrigine-induced drug adverse reaction under tocilizumab treatment with clinical and virological features of drug-induced hypersensitivity syndrome.
    J Dermatol. 2018 Mar 22. doi: 10.1111/1346-8138.14288.
    PubMed     Abstract available

  168. ISHIUJI Y, Umezawa Y, Asahina A, Fukuta H, et al
    Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
    J Dermatol. 2018 Mar 22. doi: 10.1111/1346-8138.14295.
    PubMed     Abstract available

  169. CAI L, Kaneko S, Morita E
    Changes in salivary chromogranin A levels in adults with atopic dermatitis are correlated with changes in their condition.
    J Dermatol. 2018 Mar 3. doi: 10.1111/1346-8138.14277.
    PubMed     Abstract available

    February 2018
  170. OZAWA M, Sasahara Y, Aiba S
    Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.
    J Dermatol. 2018 Feb 5. doi: 10.1111/1346-8138.14243.
    PubMed     Abstract available

  171. DENG W, Miao C, Zhang X
    Abrupt generalized pustules in patients with rheumatoid arthritis and interstitial lung disease.
    J Dermatol. 2018;45:198-201.
    PubMed     Abstract available

  172. IGARI S, Yamamoto T
    Dramatic effect of hydroxychloroquine on lupus alopecia.
    J Dermatol. 2018;45:194-197.
    PubMed     Abstract available

    January 2018
  173. ARIMA K, Gupta S, Gadkari A, Hiragun T, et al
    Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.
    J Dermatol. 2018 Jan 31. doi: 10.1111/1346-8138.14218.
    PubMed     Abstract available

  174. SAITO A, Okiyama N, Iwamoto K, Inoue S, et al
    Case with anaphylactic shock induced by heparin-lock flush injection.
    J Dermatol. 2018 Jan 25. doi: 10.1111/1346-8138.14216.

  175. HASHIZUME H, Kageyama R, Kaneko Y
    Short course of cyclosporin A as a treatment option for drug-induced hypersensitivity syndrome: Case reports and review of the published work.
    J Dermatol. 2018 Jan 8. doi: 10.1111/1346-8138.14207.

  176. LEE YB, Lee JH, Kang MJ, Choi JY, et al
    Association between allergic diseases and ophthalmologic diseases, including cataracts and glaucoma, using the Korean National Health and Nutrition Examination Survey 2010-2012: A STROBE-compliant article.
    J Dermatol. 2018 Jan 4. doi: 10.1111/1346-8138.14193.
    PubMed     Abstract available

  177. OTOBE S, Sugaya M, Nakajima R, Oka T, et al
    Increased interleukin-36gamma expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sezary syndrome.
    J Dermatol. 2018 Jan 3. doi: 10.1111/1346-8138.14198.
    PubMed     Abstract available

  178. KULTHANAN K, Tuchinda P, Likitwattananurak C, Weerasubpong P, et al
    Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients.
    J Dermatol. 2018;45:17-23.
    PubMed     Abstract available

  179. KIM BR, Yang S, Choi JW, Choi CW, et al
    Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study.
    J Dermatol. 2018;45:10-16.
    PubMed     Abstract available

  180. SUEKI H, Mizukawa Y, Aoyama Y
    Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients.
    J Dermatol. 2018;45:3-9.
    PubMed     Abstract available

    December 2017
  181. MATSUDA T, Ly NTM, Kambe N, Nguyen CTH, et al
    Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
    J Dermatol. 2017 Dec 14. doi: 10.1111/1346-8138.14156.
    PubMed     Abstract available

    November 2017
  182. YAMAUCHI A, Kubo A, Ono N, Shiohama A, et al
    Three cases of Nagashima-type palmoplantar keratosis associated with atopic dermatitis: A diagnostic pitfall.
    J Dermatol. 2017 Nov 23. doi: 10.1111/1346-8138.14152.

  183. KANEKO Y, Kageyama R, Hashizume H
    Agranulocytosis associated with voriconazole-induced hypersensitivity syndrome.
    J Dermatol. 2017 Nov 23. doi: 10.1111/1346-8138.14142.

  184. TAKEUCHI S, Oba J, Esaki H, Furue M, et al
    Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis.
    J Dermatol. 2017 Nov 23. doi: 10.1111/1346-8138.14124.
    PubMed     Abstract available

  185. KOMURA Y, Kogure T, Kawahara K, Yokozeki H, et al
    Economic assessment of actual prescription of drugs for treatment of atopic dermatitis: Differences between dermatology and pediatrics in large-scale receipt data.
    J Dermatol. 2017 Nov 23. doi: 10.1111/1346-8138.14133.
    PubMed     Abstract available

  186. WEI W, Anderson P, Gadkari A, Blackburn S, et al
    Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.
    J Dermatol. 2017 Nov 13. doi: 10.1111/1346-8138.14116.
    PubMed     Abstract available

    October 2017
  187. MATSUMOTO Y, Kadono T, Matsuoka M, Kawakami T, et al
    Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
    J Dermatol. 2017 Oct 6. doi: 10.1111/1346-8138.14091.

  188. FUJIMURA T, Kambayashi Y, Hidaka T, Tamabuchi E, et al
    Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab.
    J Dermatol. 2017 Oct 6. doi: 10.1111/1346-8138.14085.

  189. KATO M, Nitta K, Kano Y, Yamada M, et al
    Case of phenylephrine hydrochloride-induced periorbital contact dermatitis with fulminant keratoconjunctivitis causing pseudomembrane formation.
    J Dermatol. 2017 Oct 6. doi: 10.1111/1346-8138.14077.

    September 2017
  190. KAWAKAMI Y, Taga S
    Anaphylaxis due to ingestion of jellyfish with possible evidence of epicutaneous sensitization.
    J Dermatol. 2017 Sep 25. doi: 10.1111/1346-8138.14042.

  191. CIPRIANI F, Marzatico A, Ricci G
    Autoimmune diseases involving skin and intestinal mucosa are more frequent in adolescents and young adults suffering from atopic dermatitis.
    J Dermatol. 2017 Sep 19. doi: 10.1111/1346-8138.14031.
    PubMed     Abstract available

    August 2017
  192. AMAGAI Y, Katsuta C, Nomura Y, Oida K, et al
    Amelioration of atopic-like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts.
    J Dermatol. 2017 Aug 16. doi: 10.1111/1346-8138.13995.
    PubMed     Abstract available

    May 2017
  193. XU H, Li YM, Ma H, Gu WT, et al
    Mycobacterium tuberculosis found at both skin lesions and Mantoux testing site in a patient with erythema induratum of Bazin.
    J Dermatol. 2017 May 4. doi: 10.1111/1346-8138.13882.
    PubMed     Abstract available

    November 2016
  194. YAGAMI A, Furue M, Togawa M, Saito A, et al
    One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    J Dermatol. 2016 Nov 14. doi: 10.1111/1346-8138.13644.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.